Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214324) titled 'Monoclonal Gammopathies' on Oct. 2.

Study Type: Observational

Primary Sponsor: Azienda USL Reggio Emilia - IRCCS

Condition: Monoclonal Gammopathy of Undetermined Significance (MGUS) Smoldering Multiple Myeloma (SMM) Multiple Myeloma (MM)

Intervention: Other: Collection of biological material

Recruitment Status: Not recruiting

Date of First Enrollment: January 1, 2023

Target Sample Size: 60

Countries of Recruitment: Italy

To know more, visit https://clinicaltrials.gov/study/NCT07214324

Published by HT Digital Content Services with permission from Health Daily Digest....